Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 68 | 2024 | 4270 | 9.060 |
Why?
|
Graft Rejection | 55 | 2024 | 4499 | 6.450 |
Why?
|
Organ Transplantation | 15 | 2024 | 1174 | 3.340 |
Why?
|
Graft Survival | 27 | 2024 | 3890 | 3.040 |
Why?
|
Facial Transplantation | 10 | 2023 | 221 | 2.920 |
Why?
|
Immunosuppressive Agents | 28 | 2024 | 4209 | 2.880 |
Why?
|
T-Lymphocytes, Regulatory | 21 | 2024 | 3111 | 2.310 |
Why?
|
Kidney Failure, Chronic | 18 | 2024 | 2495 | 2.290 |
Why?
|
Transplantation | 4 | 2024 | 222 | 1.800 |
Why?
|
Proteinuria | 2 | 2024 | 607 | 1.460 |
Why?
|
Glomerulonephritis, Membranous | 2 | 2024 | 84 | 1.430 |
Why?
|
Interleukin-2 | 4 | 2024 | 1896 | 1.290 |
Why?
|
Matrix Metalloproteinase 3 | 2 | 2019 | 139 | 1.230 |
Why?
|
Isoantibodies | 6 | 2023 | 681 | 1.200 |
Why?
|
Heart Transplantation | 12 | 2021 | 3310 | 1.110 |
Why?
|
T-Lymphocytes | 15 | 2023 | 10261 | 1.100 |
Why?
|
Immunity, Humoral | 3 | 2022 | 605 | 1.100 |
Why?
|
Transplantation, Homologous | 14 | 2024 | 4860 | 1.070 |
Why?
|
Skin Transplantation | 4 | 2022 | 1098 | 1.020 |
Why?
|
Nephrotic Syndrome | 4 | 2024 | 380 | 1.000 |
Why?
|
Receptors, Notch | 3 | 2020 | 752 | 0.930 |
Why?
|
Living Donors | 4 | 2021 | 645 | 0.890 |
Why?
|
Desensitization, Immunologic | 2 | 2022 | 544 | 0.870 |
Why?
|
Tissue Donors | 5 | 2022 | 2395 | 0.860 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2018 | 1801 | 0.850 |
Why?
|
Tacrolimus | 3 | 2024 | 753 | 0.840 |
Why?
|
Recurrence | 9 | 2024 | 8501 | 0.830 |
Why?
|
Transplantation Immunology | 2 | 2016 | 541 | 0.830 |
Why?
|
Glomerulonephritis | 3 | 2021 | 332 | 0.770 |
Why?
|
Glomerular Filtration Rate | 6 | 2024 | 2233 | 0.770 |
Why?
|
Kidney Diseases | 6 | 2024 | 2098 | 0.760 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2022 | 669 | 0.760 |
Why?
|
Postoperative Complications | 13 | 2024 | 15747 | 0.730 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 62 | 0.720 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2024 | 333 | 0.710 |
Why?
|
Immune Tolerance | 7 | 2020 | 2324 | 0.690 |
Why?
|
Th1 Cells | 4 | 2016 | 1039 | 0.650 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2019 | 172 | 0.640 |
Why?
|
Immunity, Innate | 3 | 2023 | 3081 | 0.620 |
Why?
|
Antilymphocyte Serum | 3 | 2022 | 493 | 0.610 |
Why?
|
Brain Death | 1 | 2022 | 360 | 0.610 |
Why?
|
Aptamers, Nucleotide | 1 | 2019 | 163 | 0.610 |
Why?
|
Diet, Gluten-Free | 1 | 2021 | 285 | 0.610 |
Why?
|
Humans | 127 | 2024 | 765968 | 0.590 |
Why?
|
Dairy Products | 1 | 2021 | 491 | 0.580 |
Why?
|
Chemokines | 1 | 2022 | 956 | 0.570 |
Why?
|
Kidney Tubules, Proximal | 1 | 2019 | 386 | 0.570 |
Why?
|
Immunity, Cellular | 3 | 2022 | 1555 | 0.570 |
Why?
|
Antibodies | 3 | 2022 | 2417 | 0.560 |
Why?
|
Bone Diseases | 1 | 2021 | 411 | 0.560 |
Why?
|
Antibodies, Monoclonal | 6 | 2023 | 9249 | 0.560 |
Why?
|
Acute Kidney Injury | 5 | 2021 | 1946 | 0.550 |
Why?
|
Antigens, CD20 | 2 | 2021 | 198 | 0.540 |
Why?
|
Podocytes | 2 | 2021 | 391 | 0.540 |
Why?
|
Adaptive Immunity | 2 | 2024 | 734 | 0.530 |
Why?
|
Cyclosporine | 2 | 2016 | 778 | 0.520 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 517 | 0.520 |
Why?
|
Antigen Presentation | 2 | 2021 | 1250 | 0.520 |
Why?
|
Kidney | 15 | 2024 | 7066 | 0.520 |
Why?
|
Immunocompromised Host | 5 | 2021 | 866 | 0.510 |
Why?
|
Plasmapheresis | 4 | 2022 | 205 | 0.500 |
Why?
|
Lymphocyte Depletion | 2 | 2021 | 605 | 0.500 |
Why?
|
T-Lymphocyte Subsets | 4 | 2021 | 1811 | 0.460 |
Why?
|
Ribavirin | 1 | 2016 | 395 | 0.460 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4778 | 0.460 |
Why?
|
Transplantation, Heterologous | 4 | 2024 | 2394 | 0.460 |
Why?
|
Blood Proteins | 1 | 2019 | 1188 | 0.450 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1792 | 0.450 |
Why?
|
Mice, Inbred BALB C | 10 | 2020 | 6220 | 0.440 |
Why?
|
Lymphocyte Activation | 7 | 2016 | 5501 | 0.430 |
Why?
|
Interleukin-17 | 3 | 2020 | 921 | 0.420 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2014 | 1347 | 0.420 |
Why?
|
Histocompatibility | 1 | 2014 | 327 | 0.420 |
Why?
|
Donor Selection | 1 | 2015 | 242 | 0.420 |
Why?
|
Apolipoproteins | 1 | 2015 | 327 | 0.410 |
Why?
|
Access to Information | 1 | 2016 | 317 | 0.410 |
Why?
|
Internationality | 1 | 2018 | 1007 | 0.410 |
Why?
|
Immunomodulation | 1 | 2016 | 547 | 0.410 |
Why?
|
Computer-Assisted Instruction | 1 | 2016 | 368 | 0.410 |
Why?
|
Animals | 41 | 2024 | 168764 | 0.410 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 303 | 0.400 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3100 | 0.400 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3223 | 0.400 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 444 | 0.390 |
Why?
|
Signal Transduction | 12 | 2020 | 23601 | 0.390 |
Why?
|
Pandemics | 8 | 2020 | 8703 | 0.380 |
Why?
|
HLA Antigens | 3 | 2022 | 1339 | 0.380 |
Why?
|
Tissue and Organ Harvesting | 1 | 2014 | 373 | 0.370 |
Why?
|
Complement System Proteins | 1 | 2014 | 715 | 0.370 |
Why?
|
Membrane Proteins | 5 | 2021 | 7851 | 0.370 |
Why?
|
Tissue and Organ Procurement | 1 | 2019 | 989 | 0.360 |
Why?
|
Maternal-Fetal Exchange | 1 | 2013 | 453 | 0.360 |
Why?
|
Renal Insufficiency | 2 | 2020 | 804 | 0.360 |
Why?
|
Autoimmunity | 2 | 2019 | 1354 | 0.360 |
Why?
|
Lipoproteins, HDL | 1 | 2015 | 674 | 0.350 |
Why?
|
Immunophenotyping | 2 | 2017 | 1866 | 0.350 |
Why?
|
Antibodies, Viral | 4 | 2023 | 3211 | 0.350 |
Why?
|
Drug Resistance | 1 | 2016 | 1591 | 0.350 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2022 | 2310 | 0.340 |
Why?
|
Hypophosphatemia | 1 | 2011 | 92 | 0.340 |
Why?
|
Withholding Treatment | 1 | 2014 | 621 | 0.340 |
Why?
|
Proteome | 1 | 2019 | 1899 | 0.330 |
Why?
|
Europe | 3 | 2021 | 3423 | 0.330 |
Why?
|
Hepatitis C, Chronic | 2 | 2020 | 1032 | 0.320 |
Why?
|
Steroids | 1 | 2014 | 933 | 0.320 |
Why?
|
Th2 Cells | 3 | 2013 | 1075 | 0.320 |
Why?
|
Interferon-gamma | 2 | 2023 | 3160 | 0.310 |
Why?
|
Fractures, Bone | 1 | 2021 | 2041 | 0.310 |
Why?
|
Mice, Inbred C57BL | 15 | 2020 | 22332 | 0.310 |
Why?
|
Th17 Cells | 4 | 2021 | 786 | 0.310 |
Why?
|
Mice | 25 | 2024 | 81819 | 0.300 |
Why?
|
Immunoconjugates | 3 | 2013 | 981 | 0.300 |
Why?
|
Opportunistic Infections | 3 | 2020 | 376 | 0.300 |
Why?
|
Male | 48 | 2024 | 363698 | 0.300 |
Why?
|
Pilot Projects | 5 | 2024 | 8733 | 0.300 |
Why?
|
Kidney Function Tests | 2 | 2024 | 683 | 0.300 |
Why?
|
Antibody Formation | 2 | 2023 | 1391 | 0.290 |
Why?
|
Neoplasms | 5 | 2022 | 22340 | 0.290 |
Why?
|
Transplantation Tolerance | 2 | 2022 | 640 | 0.290 |
Why?
|
Phosphates | 1 | 2011 | 763 | 0.280 |
Why?
|
Antibodies, Blocking | 3 | 2019 | 249 | 0.280 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2012 | 504 | 0.280 |
Why?
|
Biopsy | 7 | 2024 | 6763 | 0.270 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2186 | 0.270 |
Why?
|
Thymus Gland | 1 | 2012 | 1261 | 0.270 |
Why?
|
Proteomics | 2 | 2019 | 3910 | 0.270 |
Why?
|
Granzymes | 3 | 2022 | 278 | 0.270 |
Why?
|
Retrospective Studies | 16 | 2024 | 81514 | 0.270 |
Why?
|
Learning | 1 | 2016 | 1755 | 0.260 |
Why?
|
Brazil | 2 | 2021 | 1248 | 0.260 |
Why?
|
Middle Aged | 29 | 2024 | 223009 | 0.260 |
Why?
|
Female | 44 | 2024 | 396112 | 0.260 |
Why?
|
Interleukin-6 | 2 | 2013 | 3222 | 0.260 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 1959 | 0.250 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2022 | 975 | 0.250 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2016 | 4405 | 0.250 |
Why?
|
Autoimmune Diseases | 2 | 2017 | 2226 | 0.250 |
Why?
|
Creatinine | 3 | 2019 | 1915 | 0.240 |
Why?
|
Swine | 4 | 2024 | 5988 | 0.240 |
Why?
|
Inflammation | 5 | 2023 | 10850 | 0.240 |
Why?
|
Dyslipidemias | 1 | 2012 | 869 | 0.230 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2011 | 2880 | 0.230 |
Why?
|
Down-Regulation | 1 | 2011 | 2927 | 0.230 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 2024 | 41 | 0.220 |
Why?
|
Education, Medical | 1 | 2016 | 1746 | 0.220 |
Why?
|
Lymphoproliferative Disorders | 2 | 2021 | 526 | 0.220 |
Why?
|
Skin | 4 | 2022 | 4489 | 0.220 |
Why?
|
Antiviral Agents | 1 | 2016 | 3050 | 0.220 |
Why?
|
Internet | 1 | 2016 | 3106 | 0.220 |
Why?
|
Placenta | 1 | 2013 | 1728 | 0.220 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2024 | 105 | 0.220 |
Why?
|
Prospective Studies | 9 | 2024 | 54802 | 0.220 |
Why?
|
Membrane Glycoproteins | 2 | 2011 | 3690 | 0.210 |
Why?
|
Receptors, Phospholipase A2 | 2 | 2021 | 31 | 0.210 |
Why?
|
Treatment Outcome | 14 | 2024 | 65188 | 0.210 |
Why?
|
Calcium | 1 | 2016 | 5767 | 0.210 |
Why?
|
Ligands | 5 | 2022 | 3273 | 0.210 |
Why?
|
Time Factors | 9 | 2021 | 40065 | 0.210 |
Why?
|
Cell Differentiation | 5 | 2024 | 11641 | 0.210 |
Why?
|
Colchicine | 2 | 2021 | 256 | 0.200 |
Why?
|
Galactosyltransferases | 1 | 2024 | 284 | 0.200 |
Why?
|
Adult | 22 | 2024 | 223044 | 0.200 |
Why?
|
Peptides | 2 | 2011 | 4331 | 0.200 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2022 | 126 | 0.190 |
Why?
|
Cytokines | 5 | 2021 | 7421 | 0.190 |
Why?
|
Nephrosis, Lipoid | 1 | 2021 | 45 | 0.190 |
Why?
|
Follow-Up Studies | 8 | 2024 | 39193 | 0.180 |
Why?
|
Risk Factors | 12 | 2024 | 74840 | 0.180 |
Why?
|
Prognosis | 6 | 2024 | 29922 | 0.180 |
Why?
|
Nephrology | 2 | 2024 | 270 | 0.180 |
Why?
|
Mycophenolic Acid | 3 | 2024 | 346 | 0.180 |
Why?
|
Chemokines, CC | 1 | 2022 | 285 | 0.180 |
Why?
|
Animals, Genetically Modified | 2 | 2024 | 1560 | 0.180 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2016 | 3646 | 0.180 |
Why?
|
Bone Marrow | 1 | 2011 | 2921 | 0.180 |
Why?
|
Organ Preservation | 1 | 2024 | 399 | 0.180 |
Why?
|
B-Lymphocyte Subsets | 1 | 2021 | 241 | 0.170 |
Why?
|
Nephritis, Interstitial | 1 | 2021 | 158 | 0.170 |
Why?
|
Glycolysis | 1 | 2024 | 838 | 0.170 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13648 | 0.170 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2019 | 72 | 0.160 |
Why?
|
Minerals | 1 | 2021 | 278 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 621 | 0.160 |
Why?
|
Acute Disease | 4 | 2018 | 7232 | 0.160 |
Why?
|
Germinal Center | 1 | 2022 | 379 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2020 | 4642 | 0.160 |
Why?
|
Mice, Knockout | 7 | 2013 | 14448 | 0.160 |
Why?
|
Aged | 17 | 2024 | 171117 | 0.160 |
Why?
|
Patient Selection | 2 | 2022 | 4255 | 0.160 |
Why?
|
Hyperparathyroidism | 1 | 2020 | 337 | 0.160 |
Why?
|
Incidence | 6 | 2024 | 21480 | 0.160 |
Why?
|
Endothelium, Vascular | 1 | 2011 | 4427 | 0.160 |
Why?
|
Skin Pigmentation | 1 | 2021 | 279 | 0.160 |
Why?
|
Crystallization | 1 | 2019 | 521 | 0.150 |
Why?
|
Hyperammonemia | 1 | 2019 | 80 | 0.150 |
Why?
|
Hypokalemia | 1 | 2019 | 154 | 0.150 |
Why?
|
STAT5 Transcription Factor | 1 | 2019 | 269 | 0.150 |
Why?
|
Integrin alpha Chains | 1 | 2018 | 93 | 0.150 |
Why?
|
Quality of Life | 2 | 2021 | 13462 | 0.150 |
Why?
|
Retreatment | 1 | 2020 | 598 | 0.150 |
Why?
|
Peri-Implantitis | 1 | 2020 | 124 | 0.150 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6309 | 0.150 |
Why?
|
Remission Induction | 2 | 2024 | 2411 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2022 | 2570 | 0.150 |
Why?
|
Survival Analysis | 2 | 2021 | 10070 | 0.150 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 684 | 0.150 |
Why?
|
Transplants | 1 | 2020 | 208 | 0.140 |
Why?
|
Cyclophosphamide | 2 | 2021 | 2228 | 0.140 |
Why?
|
Paraproteinemias | 1 | 2019 | 252 | 0.140 |
Why?
|
Plasma Cells | 1 | 2020 | 591 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2020 | 330 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2024 | 4044 | 0.130 |
Why?
|
North America | 1 | 2020 | 1285 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9525 | 0.130 |
Why?
|
Blogging | 1 | 2016 | 15 | 0.130 |
Why?
|
Up-Regulation | 2 | 2018 | 4137 | 0.130 |
Why?
|
Risk Assessment | 7 | 2024 | 24282 | 0.130 |
Why?
|
Autoantibodies | 2 | 2021 | 2113 | 0.130 |
Why?
|
Antigens, CD | 3 | 2018 | 4025 | 0.130 |
Why?
|
Reperfusion | 1 | 2017 | 267 | 0.130 |
Why?
|
Serpins | 2 | 2017 | 245 | 0.130 |
Why?
|
Replantation | 1 | 2017 | 146 | 0.130 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18293 | 0.130 |
Why?
|
Amputation, Traumatic | 1 | 2017 | 136 | 0.130 |
Why?
|
Albuminuria | 1 | 2019 | 660 | 0.130 |
Why?
|
Mice, Transgenic | 4 | 2019 | 9550 | 0.130 |
Why?
|
Point-of-Care Systems | 1 | 2024 | 1217 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 2 | 2024 | 1880 | 0.120 |
Why?
|
Death | 1 | 2019 | 686 | 0.120 |
Why?
|
Chronic Disease | 4 | 2018 | 9347 | 0.120 |
Why?
|
Renal Replacement Therapy | 1 | 2017 | 281 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 3 | 2016 | 1857 | 0.110 |
Why?
|
Flow Cytometry | 4 | 2013 | 5881 | 0.110 |
Why?
|
Hypoparathyroidism | 1 | 2015 | 136 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1159 | 0.110 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2013 | 58 | 0.110 |
Why?
|
Genes, MHC Class II | 2 | 2012 | 433 | 0.110 |
Why?
|
Litter Size | 1 | 2013 | 49 | 0.110 |
Why?
|
Dysuria | 1 | 2013 | 6 | 0.110 |
Why?
|
Teriparatide | 1 | 2015 | 225 | 0.110 |
Why?
|
Parathyroidectomy | 1 | 2015 | 244 | 0.110 |
Why?
|
Adoptive Transfer | 2 | 2013 | 827 | 0.110 |
Why?
|
Embryo Loss | 1 | 2013 | 55 | 0.110 |
Why?
|
Cells, Cultured | 4 | 2019 | 18973 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 2010 | 0.100 |
Why?
|
Face | 1 | 2019 | 1028 | 0.100 |
Why?
|
Exosomes | 1 | 2017 | 421 | 0.100 |
Why?
|
Complement Inactivating Agents | 2 | 2024 | 53 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2024 | 5849 | 0.100 |
Why?
|
Models, Immunological | 2 | 2013 | 517 | 0.100 |
Why?
|
Homeostasis | 2 | 2014 | 3336 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2021 | 2056 | 0.100 |
Why?
|
Mice, Inbred CBA | 1 | 2013 | 439 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1884 | 0.100 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 120 | 0.100 |
Why?
|
Intestines | 1 | 2021 | 1906 | 0.100 |
Why?
|
Dexamethasone | 1 | 2019 | 1963 | 0.100 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2018 | 1441 | 0.100 |
Why?
|
Histocompatibility, Maternal-Fetal | 1 | 2011 | 9 | 0.100 |
Why?
|
United States | 6 | 2024 | 72903 | 0.100 |
Why?
|
Histocompatibility Antigens | 1 | 2013 | 477 | 0.100 |
Why?
|
ROC Curve | 1 | 2019 | 3620 | 0.100 |
Why?
|
Hypothermia, Induced | 1 | 2017 | 752 | 0.100 |
Why?
|
Extremities | 1 | 2017 | 869 | 0.090 |
Why?
|
Biosensing Techniques | 1 | 2017 | 642 | 0.090 |
Why?
|
Cluster Analysis | 1 | 2018 | 2721 | 0.090 |
Why?
|
Immunologic Factors | 2 | 2021 | 1587 | 0.090 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1628 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8041 | 0.090 |
Why?
|
Immunoenzyme Techniques | 2 | 2011 | 1701 | 0.090 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 691 | 0.090 |
Why?
|
Calcium Compounds | 1 | 2011 | 40 | 0.090 |
Why?
|
Complement C3 | 2 | 2024 | 424 | 0.090 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 369 | 0.090 |
Why?
|
Self Tolerance | 1 | 2011 | 119 | 0.090 |
Why?
|
Immunologic Memory | 2 | 2016 | 1375 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1883 | 0.090 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 1314 | 0.090 |
Why?
|
Cause of Death | 2 | 2018 | 3708 | 0.090 |
Why?
|
Apoptosis | 3 | 2022 | 9514 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1808 | 0.080 |
Why?
|
Dendritic Cells | 2 | 2018 | 2747 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2021 | 5302 | 0.080 |
Why?
|
Growth Inhibitors | 1 | 2011 | 376 | 0.080 |
Why?
|
Lipids | 1 | 2021 | 3315 | 0.080 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1745 | 0.080 |
Why?
|
Survival Rate | 1 | 2024 | 12795 | 0.080 |
Why?
|
Vaccination | 1 | 2022 | 3426 | 0.080 |
Why?
|
Acetates | 1 | 2011 | 313 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2011 | 1151 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1892 | 0.080 |
Why?
|
Comorbidity | 2 | 2020 | 10563 | 0.080 |
Why?
|
Kidney Glomerulus | 1 | 2011 | 568 | 0.080 |
Why?
|
Publishing | 1 | 2016 | 835 | 0.080 |
Why?
|
Young Adult | 6 | 2021 | 59889 | 0.080 |
Why?
|
Multicenter Studies as Topic | 1 | 2013 | 1731 | 0.080 |
Why?
|
Ischemia | 1 | 2017 | 1909 | 0.070 |
Why?
|
Cell Polarity | 1 | 2011 | 636 | 0.070 |
Why?
|
Serine Endopeptidases | 1 | 2013 | 1024 | 0.070 |
Why?
|
Bone Density Conservation Agents | 1 | 2015 | 791 | 0.070 |
Why?
|
Canada | 2 | 2023 | 2119 | 0.070 |
Why?
|
Rabbits | 1 | 2014 | 4734 | 0.070 |
Why?
|
Bone Density | 1 | 2021 | 3491 | 0.070 |
Why?
|
Forecasting | 1 | 2017 | 2936 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7425 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2012 | 608 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12976 | 0.070 |
Why?
|
Spleen | 1 | 2013 | 2296 | 0.070 |
Why?
|
Anti-Infective Agents | 1 | 2014 | 986 | 0.070 |
Why?
|
Disease Susceptibility | 1 | 2013 | 1789 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2476 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2017 | 2243 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20124 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15880 | 0.070 |
Why?
|
Child, Preschool | 4 | 2021 | 42500 | 0.070 |
Why?
|
Genotype | 2 | 2024 | 13024 | 0.060 |
Why?
|
Prednisone | 2 | 2021 | 1565 | 0.060 |
Why?
|
Communicable Diseases | 1 | 2014 | 874 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6493 | 0.060 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 820 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 3675 | 0.060 |
Why?
|
Fever | 1 | 2013 | 1603 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 18380 | 0.060 |
Why?
|
Brain | 2 | 2022 | 27171 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2016 | 1462 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3835 | 0.060 |
Why?
|
Boston | 2 | 2014 | 9338 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6499 | 0.050 |
Why?
|
Complement C4b | 1 | 2023 | 124 | 0.050 |
Why?
|
Child | 5 | 2024 | 80564 | 0.050 |
Why?
|
Adolescent | 5 | 2024 | 88835 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11022 | 0.050 |
Why?
|
Administration, Oral | 1 | 2011 | 4015 | 0.050 |
Why?
|
Focal Adhesions | 1 | 2023 | 113 | 0.050 |
Why?
|
Risk | 1 | 2014 | 9591 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8529 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10729 | 0.050 |
Why?
|
HLA-A2 Antigen | 1 | 2022 | 207 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8297 | 0.050 |
Why?
|
Models, Animal | 2 | 2024 | 2120 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2822 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2013 | 3454 | 0.050 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2022 | 100 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11888 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5526 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2024 | 798 | 0.050 |
Why?
|
Coronary Disease | 1 | 2015 | 5912 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2020 | 137 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6610 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
Azathioprine | 1 | 2021 | 350 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2022 | 694 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 1 | 2021 | 561 | 0.040 |
Why?
|
Perfusion | 1 | 2024 | 1407 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2021 | 790 | 0.040 |
Why?
|
Polyomavirus | 1 | 2020 | 236 | 0.040 |
Why?
|
Cryopreservation | 1 | 2024 | 728 | 0.040 |
Why?
|
Infant | 1 | 2021 | 36386 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 18071 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1289 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2020 | 386 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3401 | 0.040 |
Why?
|
Vincristine | 1 | 2021 | 1039 | 0.040 |
Why?
|
Ritonavir | 1 | 2020 | 330 | 0.040 |
Why?
|
Italy | 1 | 2020 | 854 | 0.040 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 152 | 0.040 |
Why?
|
Polyomavirus Infections | 1 | 2020 | 194 | 0.040 |
Why?
|
Erythema | 1 | 2019 | 262 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 2020 | 440 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3251 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59489 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2021 | 1799 | 0.030 |
Why?
|
Heart Failure | 1 | 2021 | 11840 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2011 | 3446 | 0.030 |
Why?
|
Nephrectomy | 1 | 2021 | 927 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6544 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 14071 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15398 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 739 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 431 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 379 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2020 | 751 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2020 | 839 | 0.030 |
Why?
|
Acute Coronary Syndrome | 1 | 2008 | 2184 | 0.030 |
Why?
|
Caspase 3 | 1 | 2017 | 731 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2020 | 4348 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2021 | 617 | 0.030 |
Why?
|
Exanthema | 1 | 2019 | 502 | 0.030 |
Why?
|
Doxorubicin | 1 | 2021 | 2230 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2194 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 870 | 0.030 |
Why?
|
Immunotherapy | 2 | 2020 | 4752 | 0.030 |
Why?
|
Pregnancy | 2 | 2013 | 30260 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1432 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11499 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2020 | 1789 | 0.030 |
Why?
|
Amyloidosis | 1 | 2021 | 885 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2077 | 0.030 |
Why?
|
Cytomegalovirus Infections | 1 | 2020 | 836 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2199 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1183 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2878 | 0.030 |
Why?
|
Janus Kinases | 1 | 2013 | 253 | 0.020 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 379 | 0.020 |
Why?
|
Dental Implants | 1 | 2020 | 790 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2011 | 120 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3202 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1441 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2011 | 214 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4528 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 419 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6897 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2011 | 414 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2010 | 822 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 602 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3584 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2013 | 1202 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2010 | 1167 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2011 | 919 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 891 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3595 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3956 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41649 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2012 | 1162 | 0.020 |
Why?
|
Capillaries | 1 | 2011 | 755 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2011 | 962 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2968 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 2014 | 1149 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1966 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2329 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2011 | 1837 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2003 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2011 | 1077 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2780 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 1028 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2630 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1718 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12768 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4353 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5020 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2017 | 3800 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10383 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2015 | 4493 | 0.010 |
Why?
|
Aorta | 1 | 2010 | 2028 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2017 | 5343 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5753 | 0.010 |
Why?
|
Diabetic Nephropathies | 1 | 2008 | 969 | 0.010 |
Why?
|
Lung Transplantation | 1 | 2010 | 1311 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10808 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10429 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2900 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2013 | 3078 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11868 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 17075 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9296 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12056 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13266 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14652 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23707 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7478 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20659 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26318 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15652 | 0.000 |
Why?
|